OTCMKTS:MDRSF Medartis (MDRSF) Stock Price, News & Analysis → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free MDRSF Stock Alerts C$84.10 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share Today's RangeC$84.10▼C$84.1050-Day RangeC$77.96▼C$84.1052-Week RangeC$84.10▼C$84.10VolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartShort InterestStock AnalysisChartShort Interest Get Medartis alerts: Email Address Ad Wealthpin ProThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. About Medartis Stock (OTCMKTS:MDRSF)Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. It serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. The company was founded in 1997 and is headquartered in Basel, Switzerland.Read More MDRSF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MDRSF Stock News HeadlinesMarch 6, 2024 | morningstar.comSIG Group AG Ordinary Shares SIGNFebruary 16, 2024 | morningstar.comMedartis Holding AG Ordinary SharesSeptember 19, 2023 | jp.reuters.comMedartis Holding AGJuly 17, 2023 | investing.comMedartis Holding AG (MEDA)May 31, 2023 | fool.comAmerican Well (NYSE: AMWL)May 18, 2023 | finance.yahoo.comSentiment Still Eluding Medartis Holding AG (VTX:MED)See More Headlines Receive MDRSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medartis and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:MDRSF CUSIPN/A CIKN/A Webwww.medartis.com Phone41 61 633 34 34FaxN/AEmployees747Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesDr. Christoph Bronnimann (Age 58)CEO & Member of Executive Management Board Comp: $1.49MDr. Thomas Straumann (Age 61)Founder & Vice Chairman Comp: $318.56kDr. Dirk W. Kirsten (Age 56)CFO & Member of the Executive Management Board Ms. Mareike Loch (Age 54)VP of EMEA & Member of Executive Management Board Mr. Manuel Schaer (Age 54)CTO & Member of the Executive Board Mr. Mario Della Casa (Age 49)COO & Member of Management Board Ms. Inge MaesChief Human Resources Officer & Executive Management Board MemberMr. Fabian HildbrandHead of Corporate CommunicationsMs. Anisha WhartonHead of Regulatory AffairsMore ExecutivesKey CompetitorsAinosNASDAQ:AIMDWBICO Group AB (publ)OTCMKTS:CLLKFBone BiologicsNASDAQ:BBLGWCaliber Imaging & DiagnosticsOTCMKTS:LCDXCell MedXOTCMKTS:CMXCView All Competitors MDRSF Stock Analysis - Frequently Asked Questions How have MDRSF shares performed in 2024? Medartis' stock was trading at C$77.96 at the beginning of 2024. Since then, MDRSF shares have increased by 7.9% and is now trading at C$84.10. View the best growth stocks for 2024 here. How do I buy shares of Medartis? Shares of MDRSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:MDRSF) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & CompanyBiden replacement revealed?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medartis Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.